Found 9 matching trials
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations PHASE3 The purpose of this Phase III study is to evaluate the efficacy and safety ...
Show More Learn More & Join Trial
Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO). PHASE3 Subjects who completed either OBERON or TITANIA will be offered the opportu...
Show More Learn More & Join Trial
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis PHASE2 This is a research study to determine the efficacy and safety of investigat...
Show More Learn More & Join Trial
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids PHASE2 This is a dose-range finding, double-blind, placebo-controlled, phase IIb s...
Show More Learn More & Join Trial
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations. PHASE3 The purpose of this Phase III study is to evaluate the efficacy and safety ...
Show More Learn More & Join Trial
An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab PHASE1 The purpose of this study is to compare the pharmacokinetic (PK) exposures ...
Show More Learn More & Join Trial
A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers PHASE1 The study will assess the relative bioavailability between two dosage forms...
Show More Learn More & Join Trial
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen PHASE3 The purpose of this study is to evaluate the effect of tozorakimab, as an a...
Show More Learn More & Join Trial
Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations PHASE3 ROMEO is a Phase III, multicentre, open-label, chronic-dosing extension stu...
Show More Learn More & Join Trial